Erratum to "Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis" [Journal of Affective Disorders 278C (2021) 542-555]

Affiliations

¹ Department of Psychiatry, Queen's University, Kingston, ON, Canada; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.
² Department of Psychiatry, Queen's University, Kingston, ON, Canada.
³ Section Neurobiology and Treatment of Mood Disorders, Division of Intramural Research Program, National Institute of Mental Health, 10 Center Drive, MSC 1282, Building 10CRC, Room 7-5342, Bethesda, MD 20892, USA. Electronic address: zaratec@mail.nih.gov.

Published Erratum

Anees Bahji et al. J Affect Disord. 2021.

. 2021 Feb 15:281:1001.

doi: 10.1016/j.jad.2020.11.103. Epub 2020 Nov 20.

¹ Department of Psychiatry, Queen's University, Kingston, ON, Canada; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.
² Department of Psychiatry, Queen's University, Kingston, ON, Canada.
³ Section Neurobiology and Treatment of Mood Disorders, Division of Intramural Research Program, National Institute of Mental Health, 10 Center Drive, MSC 1282, Building 10CRC, Room 7-5342, Bethesda, MD 20892, USA. Electronic address: zaratec@mail.nih.gov.

No abstract available

Erratum for

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
Bahji A, Vazquez GH, Zarate CA Jr. Bahji A, et al. J Affect Disord. 2021 Jan 1;278:542-555. doi: 10.1016/j.jad.2020.09.071. Epub 2020 Sep 23. J Affect Disord. 2021. PMID: 33022440 Free PMC article.